In male patients with comorbid alcohol use disorder and PTSD, neither 20 IU nor 40 IU intranasal oxytocin reduced self-reported cue-induced alcohol craving versus placebo.
In plain wordsIn men with alcohol use disorder and PTSD, oxytocin did not reduce alcohol craving triggered by cues, compared with placebo.
- Peptide
- Oxytocin
- Outcome
- No significant changeCue-induced alcohol craving (self-reported)
- Study
n = 47
- Comparator
- Placebo
- Outcome group
- Addiction, withdrawal and alcohol intake · Mental health and mood
- Studied dose
- 20 IU and 40 IU · intranasal · single dose per visitAs given in this study (human).
Source sentences
While alcohol cues significantly induced self-reported craving and increased HR compared to neutral water cues, neither dosage of oxytocin compared to placebo reduced self-reported cue-induced alcohol craving nor cue-induced changes in HR in patients with PTSD-AUD.
2 context sentences(design, population, supporting numbers)
Forty-seven male patients with comorbid AUD-PTSD were administered intranasal oxytocin in a randomized, double-blind, dose-ranging (20 IU, 40 IU, and matched placebo), within-participant design with study visits at least 1 week apart.
A cue-induced craving paradigm was conducted using each participant's preferred alcoholic beverage versus a neutral water cue.